Delivery Order SPE2DB24D2205-SPE2DB25FEGTJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,846.23 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed price, non-set-aside contract with performance location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,114.24 for Freestyle Libre 3 sensors on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,787.58 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Sensors. This is a firm fixed price, non-set-aside contract that represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,895.37 for Freestyle Libre 3 sensors on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a direct procurement for continuous glucose monitoring devices to support military and federal healthcare operations. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,059.60 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,392.00 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor whose corporate office is located in Conshohocken, Pennsylvania. The sensors will be delivered to the same location, supporting federal medical supply requirements....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,788.78 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors. This firm fixed-price contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive, non-set-aside award. The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,972.90 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,946.79 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors. This competitively awarded, firm fixed price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. The award carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive partnership with DLA to supply critical medical devices and pharmaceuticals to support military and federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,249.41 delivery order on August 7, 2025, for Freestyle Libre 3 sensors. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGTJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,100.64 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on August 25, 2025, with an ultimate completion date of August 26, 2025. This is a firm fixed price, non-set-aside contract for delivery to the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a discrete procurement of continuous glucose monitoring sensors to support military and federal healthcare operations through DLA's medical supply chain. This award is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting portfolio with DLA and competes successfully for open market awards across multiple therapeutic domains, demonstrating its capability to fulfill diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/25/25 |